4.5 Article

Assays for L-type voltage gated calcium channels

期刊

ANALYTICAL BIOCHEMISTRY
卷 656, 期 -, 页码 -

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ab.2022.114827

关键词

L-type voltage gated calcium channel; Drug discovery; VGCC assay; Calcium imaging; End-point assay for calcium channel; HEK-293

资金

  1. Rajiv Gandhi Centre for Biotechnology (RGCB), Government of India
  2. CSIR, Government of India

向作者/读者索取更多资源

This study reports the presence of L-type VGCC subunit proteins in HEK-293 cells and develops simple methods for its assay. The activity of L-VGCC in HEK-293 cells can be detected through endogenous expression, eliminating the need for transfection. Different experimental methods were used to detect the activity, and the antagonist nifedipine was found to block the activity. These findings offer commercially viable assays for drug screening.
Voltage gated calcium channels (VGCCs) are pursued as drug targets for neurodegenerative and cardiovascular diseases. High throughput drug screening targeting VGCCs depends on patch-clamp electrophysiology or fluorophore-based calcium imaging that requires powerful equipment and specialized expertise thus leading to cost escalation. Moreover, VGCC needs to be transfected into cell lines such as HEK-293. We report the presence of L-type VGCC (L-VGCC) subunit proteins, Cav1.2, alpha 2 delta and beta in HEK-293 cells and the application of simple methods for its assay. Endogenous expression of the channel in HEK-293 cells overcomes the need for transfection. L-VGCC in HEK-293 cells was activated either by the agonist, BayK8644 or by KCl-mediated depolarization. Activity was detected using the calcium sensing probe, GCaMP6m by live imaging. L-VGCC activity induced enhancement in GCaMP6m fluorescence returned to baseline corresponding to channel-closure. Activity was also shown using a methodology involving end-point detection of the calcium dependent interaction of alpha-CaMKII with NMDA receptor subunit GluN2B sequence. This methodology further simplifies the assay as it eliminates the need for real time imaging. Activation was blocked by the specific L-type VGCC antagonist, nifedipine. Finding the protein and activity of L-VGCC in HEK-293 cells offers commercially viable assays for drug screening.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据